Tag Archives: Johnson & Johnson

Challenging Entrepreneurs to Heal the World


The healthcare industry needs a refresh! Through improvements in medicine, sanitation and general living conditions, we’ve made great strides at fighting many of the maladies that have plagued humanity for centuries, lowering child mortality rates while increasing life spans by decades. Yet as a consequence of living longer, we’re facing new health issues and the increasing prevalence of chronic conditions and , neurodegenerative,  metabolic and immunological diseases. Despite scientific advancements in many fields, insufficient progress Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Strategic Venture Investing by Large Pharma: Is “Smart Money” Right for Your Company

health care, medicine

The strategic venture arms of major biopharma companies like AbbVie, Amgen, Johnson & Johnson and Pfizer offer unique value propositions to early-stage companies and have the flexibility to shape unique deal structures for advancing these partnerships beyond traditional corporate venture capital models. Speakers at a 2016 BIO International Convention panel titled “Strategic Venture Investing by Large Pharma: Is ‘Smart Money’ Right for Your Company?” provided their about how these venture arms fuel innovation in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Patents Not an Issue in the Fight Against Ebola


As of October 23,2014 more than 4,900 people have died from the current Ebola outbreak, concentrated in the three West African countries of Sierra Leone, Guinea, and Liberia. Frustrated that the process of getting experimental vaccines to West Africa was not moving fast enough, some were quick to blame intellectual property rights. But in reality, as government officials were quick to point out, the WHO first needed to resolve important ethical and safety considerations before a vaccine that Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Fireside Chat with Ken Drazan, MD, Head of Johnson & Johnson Innovation

Ken Drazan, MD

Day one of the BIO Investor Forum featured a Fireside Chat with Ken Drazan, MD, who serves as the head of Johnson & Johnson Innovation in California. The conversation was moderated by Deepa R. Pakianathan, PhD, a general partner for Delphi Ventures who leads the firm’s biotechnology investment activities. Ken Drazan has a unique viewpoint which results from having experience with both the biopharma start-up world as well as in the investment community. This background Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

My Regeneration


What can today’s generation hope for from regenerative medicine? It’s a frontier for business, the medical profession and society. Regenerative medicine aims to shift the focus from palliative care to the development of treatments that address diabetes, Parkinson’s disease, stroke and heart disease. The hope is that we’ll live longer, healthier lives and have greater independence in old age, thereby reducing the burden on healthcare systems. Given global population demographics, this is essential: according to the World Health Organisation by Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,